Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.46 |
| ▸ | MEN1 | O00255 | 7/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.46 |
| ▸ | HPGD | P15428 | 5/20 | 0.46 |
| ▸ | MAPT | P10636 | 5/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.45 |
| ▸ | DPP4 | P27487 | 1/20 | 0.45 |
| ▸ | RECQL | P46063 | 1/20 | 0.45 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.43 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.43 |
| ▸ | PPARG | P37231 | 2/20 | 0.43 |
| ▸ | NCOA2 | Q15596 | 1/20 | 0.43 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.43 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.43 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.43 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10000975 | 0.92 | MEN1 (0.45) | ALDH1A1KDM4EMEN1KMT2AHPGD | |
| SCHEMBL595855 | 0.92 | ADORA2A (0.45) | ALDH1A1KDM4EMEN1KMT2AHPGD | |
| SCHEMBL25850701 | 0.90 | ALDH1A1 (0.40) | ALDH1A1KDM4EMEN1KMT2AHPGD | |
| SCHEMBL14560694 | 0.87 | KDM4E (0.57) | ALDH1A1KDM4EMEN1KMT2AHPGD | |
| SCHEMBL13458726 | 0.87 | KDM4E (0.57) | ALDH1A1KDM4EMEN1KMT2AHPGD | |
| SCHEMBL29455177 | 0.87 | KDM4E (0.57) | ALDH1A1KDM4EMEN1KMT2AHPGD | |
| SCHEMBL347336 | 0.86 | ADORA1 (0.42) | ALDH1A1KDM4EMEN1KMT2AHPGD | |
| SCHEMBL3697872 | 0.86 | KDM4E (0.56) | ALDH1A1KDM4EMEN1KMT2AHPGD | |
| SCHEMBL13458698 | 0.86 | KDM4E (0.56) | ALDH1A1KDM4EMEN1KMT2AHPGD | |
| SCHEMBL3699265 | 0.86 | KDM4E (0.56) | ALDH1A1KDM4EMEN1KMT2AHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2789027-B1 | ORGANIC PHOTOVOLTAIC DEVICE | NOVALED GMBH (DE) | 2019-08-14 | — | — | EP | disclosed |
| EP-2789028-B1 | ORGANIC LIGHT EMITTING DEVICE AND METHOD OF PRODUCING | NOVALED GMBH (DE) | 2019-02-06 | — | — | EP | disclosed |
| US-9318705-B2 | Organic light emitting device with roughening layer and method of producing | NOVALED GMBH (DE) | 2016-04-19 | — | — | US | disclosed |
| US-9178173-B2 | Organic light emitting device | NOVALED AG (DE) | 2015-11-03 | — | — | US | disclosed |
| US-20140332794-A1 | Organic Light Emitting Device and Method of Producing | NOVALED GMBH (DE) | 2014-11-13 | — | — | US | disclosed |
| US-20140326310-A1 | Organic Photovoltaic Device | NOVALED GMBH (DE) | 2014-11-06 | — | — | US | disclosed |
| EP-2789028-A1 | ORGANIC LIGHT EMITTING DEVICE AND METHOD OF PRODUCING | Novaled GmbH (DE) | 2014-10-15 | — | — | EP | disclosed |
| US-20130320307-A1 | Organic Light Emitting Device | NOVALED AG (DE) | 2013-12-05 | — | — | US | disclosed |
| WO-2013083712-A1 | ORGANIC LIGHT EMITTING DEVICE AND METHOD OF PRODUCING | NOVALED AG (DE) | 2013-06-13 | — | — | WO | disclosed |
| US-8329898-B2 | Pyrido[3,2-h]quinazolines and/or 5,6-dihydro derivatives thereof, a method for the production thereof and doped organic semiconductor material containing these | NOVALED AG (DE) | 2012-12-11 | — | — | US | disclosed |
| US-20120041197-A1 | Pyrido[3,2-h]quinazolines and/or 5,6-dihydro Derivatives Thereof, a Method for the Production Thereof and Doped Organic Semiconductor Material Containing These | NOVALED AG (DE) | 2012-02-16 | — | — | US | disclosed |
| US-8115003-B2 | Pyrido[3,2-h]quinazolines and/or 5,6-dihydro derivatives thereof, a method for the production thereof and doped organic semiconductor material containing these | NOVALED AG (DE) | 2012-02-14 | — | — | US | disclosed |
| WO-2011157385-A2 | ORGANIC LIGHT EMITTING DEVICE | NOVALED AG (DE) | 2011-12-22 | — | — | WO | disclosed |
| US-20110046374-A1 | Pyrido[3,2-h]quinazolines and/or 5,6-dihydro Derivatives Thereof, a Method for the Production Thereof and Doped Organic Semiconductor Material Containing These | NOVALED AG (DE) | 2011-02-24 | — | — | US | disclosed |
| US-7807687-B2 | Pyrido[3,2-h]quinazolines and/or 5,6-dihydro derivatives thereof, a method for the production thereof and doped organic semiconductor material containing these | NOVALED AG (DE) | 2010-10-05 | — | — | US | disclosed |
| EP-1970371-B1 | Pyrido(3,2-h)chinazolins and/or 5,6-Dihydro derivatives thereof, method for their manufacture and endowed organic semiconductor material containing them | NOVALED AG (DE) | 2010-08-25 | — | — | EP | disclosed |
| US-20080227979-A1 | Pyrido[3,2-h]quinazolines and/or 5,6-dihydro derivatives thereof, a method for the production thereof and doped organic semiconductor material containing these | NOVALED AG (DE) | 2008-09-18 | — | — | US | disclosed |
| EP-1970371-A1 | Pyrido(3,2-h)chinazolins and/or 5,6-Dihydro derivatives thereof, method for their manufacture and endowed organic semiconductor material containing them | Novaled AG (DE) | 2008-09-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120041197-A1 | Pyrido[3,2-h]quinazolines and/or 5,6-dihydro Derivatives Thereof, a Method for the Production Thereof and Doped Organic Semiconductor Material Containing These | PDXK, PNPO, QDPR | ALDH1A1 1907/4885KDM4E 1296/4885MEN1 2966/4885 |
| US-20080227979-A1 | Pyrido[3,2-h]quinazolines and/or 5,6-dihydro derivatives thereof, a method for the production thereof and doped organic semiconductor material containing these | PDXK, PNPO, QDPR | ALDH1A1 1907/4885KDM4E 1296/4885MEN1 2966/4885 |
| US-20110046374-A1 | Pyrido[3,2-h]quinazolines and/or 5,6-dihydro Derivatives Thereof, a Method for the Production Thereof and Doped Organic Semiconductor Material Containing These | PDXK, PNPO, QDPR | ALDH1A1 1907/4885KDM4E 1296/4885MEN1 2966/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.